These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 445815)
61. [Value of the determination of carcinoembryonic antigen (CEA) in benign and tumoral digestive pathology, chronic hepathopathies and hepatomas: study of 190 cases]. Escudero Navarro JM; Rodrigo Saez L; Morcillo Herrera L; Faedo Presa I; Cornago Sánchez A; Pérez Alvarez R; García Saavedra L Rev Esp Enferm Apar Dig; 1980 Sep; 58(3):267-74. PubMed ID: 6256829 [No Abstract] [Full Text] [Related]
62. Detection of tumor antibodies in patients with gastrointestinal carcinomas by a solid-phase radioimmunoassay. Berczi I; McMorris LS; Thoriakson TK; Thoriakson RH; Kellen JA; Sehon AH J Natl Cancer Inst; 1979 Sep; 63(3):553-66. PubMed ID: 288924 [TBL] [Abstract][Full Text] [Related]
63. Nature and significance of the antigens associated with human gastrointestinal tumours. Burtin P J Clin Pathol Suppl (R Coll Pathol); 1974; 7():115-8. PubMed ID: 4598346 [No Abstract] [Full Text] [Related]
64. [Evaluation of a new CEA RIA kit]. Kanamori I; Nakano S; Yabashi T; Matsuo S; Kawase A; Yanase M; Hattori Y; Higuchi C Radioisotopes; 1984 Feb; 33(2):81-4. PubMed ID: 6739862 [No Abstract] [Full Text] [Related]
65. CA 72-4 radioimmunoassay for the detection of the TAG-72 carcinoma-associated antigen in serum of patients. Gero EJ; Colcher D; Ferroni P; Melsheimer R; Giani S; Schlom J; Kaplan P J Clin Lab Anal; 1989; 3(6):360-9. PubMed ID: 2614571 [TBL] [Abstract][Full Text] [Related]
66. [Critical evaluation of the results of determination of carcinoembryonic antigen (CEA) by the radioimmunoassay method]. Bombardieri E; Rodari A; Turrin A; Ringhini R; Buraggi GL Radiol Med; 1977 Sep; 63(9):786-8. PubMed ID: 614641 [No Abstract] [Full Text] [Related]
67. [A study of sputum beta 2-microglobulin and carcinoembryonic antigen in patients with primary lung cancer]. Fujii M; Tamai M Gan No Rinsho; 1985 Jun; 31(7):799-802. PubMed ID: 3897623 [TBL] [Abstract][Full Text] [Related]
68. Carcinoembryonic antigen: its role as a marker in the management of cancer. Summary of an NIH consensus statement. Br Med J (Clin Res Ed); 1981 Jan; 282(6261):373-5. PubMed ID: 6780032 [No Abstract] [Full Text] [Related]
69. [Basic and clinical evaluation of Phadebas CEA Prist kit]. Yoshii M; Nakajima K; Morita R; Torizuka K Kaku Igaku; 1983 Feb; 20(1):91-7. PubMed ID: 6876496 [No Abstract] [Full Text] [Related]
70. [Radioimmunologic determination of carcinoembryonic antigen (CEA). Current viewpoints and personal experience]. Lupo A Minerva Dietol Gastroenterol; 1978; 24(2):89-96. PubMed ID: 733032 [No Abstract] [Full Text] [Related]
71. Immunohistological localization of carcinoembryonic antigen and nonspecific cross-reacting antigen in gastrointestinal normal and tumoral tissues. Burtin P; von Kleist S; Sabine MC; King M Cancer Res; 1973 Dec; 33(12):3299-305. PubMed ID: 4586525 [No Abstract] [Full Text] [Related]
72. Carcinoembryonic antigen. Quantitative variations in circulating levels in benign and malignant digestive tract diseases. Zamcheck N Adv Intern Med; 1974; 19():413-33. PubMed ID: 4592719 [No Abstract] [Full Text] [Related]
73. The combined use of CA 19-9 and carcino-embryonic antigen (CEA) in malignancies of the gastrointestinal tract. Staab HJ Acta Gastroenterol Belg; 1987; 50(1):29-35. PubMed ID: 3480668 [No Abstract] [Full Text] [Related]
74. A comparison of two radioimmunoassay methods for the detection of carcinoembryonic antigen in patients with ovarian or cervical cancer. Magon H; Daunter B; Khoo SK; Mackay EV Gynecol Oncol; 1981 Jun; 11(3):340-7. PubMed ID: 7250759 [No Abstract] [Full Text] [Related]
75. [The usefulness of the quantitative evaluation of the plasma levels of the carcinoembryonic antigen (CEA) in patients with respiratory neoplasms (author's transl)]. Richart C; Ruibal A; Monné J Med Clin (Barc); 1979 Oct; 73(6):239-41. PubMed ID: 232738 [TBL] [Abstract][Full Text] [Related]
76. [Serum CEA determinatio in various diseases with CEA-Roche Kit--experimental studies and clinical evaluation]. Yoshii M; Ishikawa E; Torizuka K; Hamada T Kaku Igaku; 1976 Aug; 13(4):521-31. PubMed ID: 988356 [No Abstract] [Full Text] [Related]
77. Circulating carcinoembryonic antigen levels and serum suppression of phytohemagglutinin-stimulated lymphocyte DNA synthesis: an inverse correlation in the cancer patient. Steward AM; Kupchik HZ; Zamcheck N J Natl Cancer Inst; 1974 Jul; 53(1):3-9. PubMed ID: 4835096 [No Abstract] [Full Text] [Related]
78. [Fundamental and clinical evaluation of CEA kit (CEA . RIABEAD)]. Kuwabara Y; Ichiya Y; Baba Y; Ayabe Z; Wada M; Katsuragi M; Matsuura K Kaku Igaku; 1984 Nov; 21(11):1513-9. PubMed ID: 6530830 [No Abstract] [Full Text] [Related]
79. [Proceedings: Immunochemical studies on carcinoembryonic antigen (CEA) and related antigens]. Kawarada S; Araki A; Taniuchi A; Wada T Hokkaido Igaku Zasshi; 1975 Jan; 50(1):80. PubMed ID: 1171064 [No Abstract] [Full Text] [Related]
80. Circulating carcinoembryonic antigen immune complexes in sera of patients with carcinomata of the gastrointestinal tract. Kapsopoulou-Dominos K; Anderer FA Clin Exp Immunol; 1979 Feb; 35(2):190-5. PubMed ID: 108040 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]